SELECT COUNTRY

VIEW ALL

AFRICA

AMERICAS

ASIA

EUROPE

OCEANIA

ALGERIA ANGOLA ARGENTINA AUSTRALIA AZERBAIJAN BAHREIN BELGIUM BENIN BOLIVIA BOTSWANA BRAZIL BRUNEI BURKINA FASO CAMEROON CANADA CENTRAL AFRICAN REPUBLIC CHAD CHILE CHINA COLOMBIA COTE D’IVOIRE CZECH REPUBLIC DOMINICAN REPUBLIC DRC ECUADOR EGYPT ETHIOPIA FINLAND FRANCE GABON GHANA GREENLAND GUINEA HUNGARY ICELAND INDIA INDONESIA IRAN IRAQ ITALY KAZAKHSTAN KENYA KUWAIT LESOTHO LIBERIA MADAGASCAR MALAWI MALAYSIA MALI MAURITANIE MEXICO MONGOLIA MOROCCO MOZAMBIQUE NAMIBIA NETHERLANDS NICARAGUA NIGER NIGERIA NORWAY PANAMA PAPUA NEW GUINEA PERU PHILIPPINES POLAND QATAR REPUBLIC OF CONGO RUSSIA RWANDA SENEGAL SINGAPORE SLOVENIA SOMALI SOUTH AFRICA SOUTH KOREA SPAIN SWEDEN TAIWAN TANZANIA THAILAND TOGO TRINDAD & TOBAGO TURKEY TURKMENISTAN UAE UGANDA UKRAINE UNITED KINGDOM UNITED STATES VENEZUELA VIETNAM ZAMBIA ZIMBABWE

LATEST INTERVIEWS MORE INTERVIEWS

Peter Meath

MANAGING DIRECTOR, CO-HEAD OF HEALTHCARE AND LIFE SCIENCES,...

"What we are seeing is a reflection of the power of genetic medicine, where the technology has demonstrated clinical promise, as well as safety. Now, in many aspects, it is up to the manufacturing to catch up as that demand for gene therapy manufacturers far exceeds the capacity."

United States

Pharmaceuticals

Timothy J. Miller

PRESIDENT & CEO, FORGE BIOLOGICS

United States

Pharmaceuticals

Lesley Millar-Nicholson

DIRECTOR, MIT TECHNOLOGY LICENSING OFFICE

"MIT spins out over 32 startup companies per year approximately, and we have about 358 companies that are still alive, so the ecosystem is functioning well."

United States

Pharmaceuticals

Darío Barros Izquierdo

GENERAL MANAGER, ECHEVERRIA IZQUIERDO MONTAJES INDUSTRIALES

"The challenge for the construction sector is to not overreact to any situation and also take a longer-term view, using this time as an opportunity to be creative and innovative, incorporate new technology and be more productive and sustainable."

Mining

Chile

LATEST ARTICLES

United States

Pharmaceuticals

Funding Environment: Life Sciences Enter the Mainstream

April 15, 2021

The past 12 months been transformative for the life science industry in USA and GBR explores how the funding environment has evolved to provide the influx of capital to sustain its innovations.